Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis

How to Cite

OrthoEvidence. Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis. ACE Report. 2021;10(1):16. Available from: https://myorthoevidene.com/AceReport/Report/12935

Study Type:Therapy

OE Level Evidence:1

Journal Level of Evidence:1

A short-term oral corticosteroid for refractory lumbar spinal stenosis: a double-blinded randomized placebo-controlled clinical trial

Int J Rehabil Res. 2020 Dec;43(4):342-346.

Contributing Authors: H Akbari Aghdam A Andalib H Asadiyan Ardakani M Telloo E Sheikhbahaei

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety-three patients with refractory lumbar spinal stenosis (LSS) were randomized to receive 1 week of oral corticosteroid (prednisolone; n=47) or a placebo (n=46) for the improvement of functionality and relief of pain. The primary outcomes of interest was the improvement in walking distance and Oswestry Disability Index (ODI). The secondary outcomes of interest was pain score on a Numeric Ratin...